Contrave: Latest Casualty in the FDA's War Against Obesity DrugsForbes (blog)Take one of Contrave's Phase 3 studies: the drug was given on top of “intensive lifestyle interventions” that included counseling, diet, and exercise. This “placebo” treatment led to a respectable 5.1% weight loss after 52 weeks. …and more » View full post on Diet Weight Loss [...]
The U.S. Food and Drug Administration (FDA) will not approve the diet drug Contrave until the drugmaker conducts studies into heart risks. View full post on MyDietExercise.com – Latest Diet & Exercise News
Press TV Contrave Weight Loss Treatment Denied FDA ApprovalInternetbitsThe ability of Contrave to assist obese patients with losing weight and then maintain at least a 5% weight loss over a year's duration was the focus of the …FDA denies approval of weight-loss drug ContraveLos Angeles TimesBreaking News: FDA gives Contrave complete response letterModernMedicineall 20 news [...]
Los Angeles Times FDA rejects weight loss drug ContraveBoston Globe“You have life-threatening possible side effects in return for modest weight loss that might not be produced in the real world — no wonder the FDA wants …FDA denies approval of weight-loss drug ContraveLos Angeles TimesWeight Loss Drug Contrave Rejected by FDAHealthNewsFactbox: A troubled history for [...]
Los Angeles Times FDA denies approval of weight-loss drug ContraveLos Angeles Times… the agency rejected another experimental diet drug called Lorqess that appeared to cause tumor growth in animals. Also in October, the weight-loss drug …Factbox: A troubled history for weight-loss drugsReutersWeight Loss Drug Contrave Rejected by FDAHealthNewsHealth Buzz: FDA Nixes Weight-Loss Drug Over Heart [...]
Los Angeles Times FDA won't approve weight-loss drug ContraveKansas City Star… the agency rejected another experimental diet drug called Lorqess that appeared to cause tumor growth in animals. Also in October, the weight loss drug …Factbox: A troubled history for weight-loss drugsReutersWeight Loss Drug Contrave Rejected by FDAHealthNewsHealth Buzz: FDA Nixes Weight-Loss Drug Over Heart [...]
Los Angeles Times Weight Loss Drug Contrave Rejected by FDAHealthNewsOne, two, three strikes and all three weight-loss drugs brought before the FDA are out of the game…maybe. Last summer, the Food & Drug …Factbox: A troubled history for weight-loss drugsReutersFDA Won't Approve Weight Loss Drug ContraveWebMDHealth Buzz: FDA Nixes Weight-Loss Drug Over Heart RisksU.S. News [...]
Post Chronicle FDA Won't Approve Weight Loss Drug ContraveWebMDContrave is the third weight loss drug in recent months to be rejected. The FDA formally rejected locaserin from Arena Pharmaceuticals and Qnexa from Vivus …Factbox: A troubled history for weight-loss drugsReutersHealth Buzz: FDA Nixes Weight-Loss Drug Over Heart RisksU.S. News & World ReportFDA Rejects Diet Pill, [...]
Proactive Investors USA & Canada Orexigen Weight Loss Drug, Contrave, Rejected By FDA, Safety ReasonsDaily Health ReportGovernment officials asked for an additional study involving heart health and the weight loss drug, Contrave. The drug is a mixture of an antidepressant and …FDA Rejects Diet Pill, Casting Pall Over Future Of Weight-Loss MedicinesNPR (blog)Summary Box: FDA [...]